Ulipristal acetate 30mg tablets for emergency contraception

Provenance

Written by SPS and the College of Sexual and Reproductive Healthcare (CoSRH), with the support of specialist stakeholders working within clinical practice, for use within reproductive services.

August 2025 – note the Faculty of Sexual and Reproductive Healthcare (FSRH) has now changed its name to the College of Sexual and Reproductive Healthcare (CoSRH). Some web pages and CoSRH documents will continue to display the FSRH name; where you see FSRH, this refers to CoSRH. All weblinks are still active.

Planned Review

Following the December 2025 launch of revised UKMEC guidelines from CoSRH, all reproductive health PGD/protocols are being reviewed to ensure they reflect the updated UKMEC.

There are no expected changes in the content of this PGD template.

PGD template attachment

The template PGD is attached below to download and use in conjunction with our implementation advice (SPS page).

• Ulipristal National PGD template V3.0 accessible 10.25Opens in a new window · Word · 98 KB

Patient Group Directions, Templates, Reproductive health

• Levonorgestrel 1500 microgram tablets for emergency contraception
• Medroxyprogesterone acetate (SC-DMPA) injection for contraception
• Combined hormonal contraceptive transdermal patch
• Combined hormonal contraceptive vaginal ring
• Progestogen only pill (POP) for contraception
• Lidocaine plus prilocaine cream for IUD insertion or removal
• Combined oral hormonal contraceptive (COC) in reproductive health
• Medroxyprogesterone acetate (DMPA) IM injection for contraception
• Lidocaine 10mg/ml spray for IUD insertion or removal
• Progestogen-Only Intra-Uterine Device (LNG-IUD) for contraception
• Lidocaine injection for subdermal etonogestrel in contraception
• Etonogestrel (e.g. Nexplanon®) implant for contraception
• Copper Intrauterine Device (Cu-IUD)

All PGD templates

Update history